Clinical Trials Browser

Phase 1/2 × Lymphoma × apraglutide × Clear all

NCT03417765 2024-10-24

Safety, Tolerability, PK/PD of FE 203799 in Adults With Lymphomas

Phase 1/2 Withdrawn

Hodgkin Disease, Lymphoma, Mucositis